Tag: Monte Rosa Therapeutics
Monte Rosa Therapeutics ($GLUE) Advances MGD Drug Discovery, Shares Climb 4% After Hours
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) shares were up 4.31% in the after-hours session on Thursday, July 3, 2025, trading at $5.08 following publication...
Monte Rosa Therapeutics, Inc. ($GLUE) Gains Spotlight with Breakthrough Study
Monte Rosa Therapeutics, Inc. (GLUE) announced the publication of groundbreaking new discoveries. These findings were featured on the cover of Science. The research article...